Nanosonics Limited Logo

Nanosonics Limited

NAN.AX

(1.5)
Stock Price

3,59 AUD

9.04% ROA

9.24% ROE

64.4x PER

Market Cap.

1.259.768.640,00 AUD

6.54% DER

0% Yield

9.43% NPM

Nanosonics Limited Stock Analysis

Nanosonics Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Nanosonics Limited Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (8%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

ROE in an average range (2.73%) suggests satisfactory profitability and decent utilization of shareholders' equity.

3 ROA

The stock's ROA (2%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 Assets Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

5 Buffet Intrinsic Value

The company's stock seems undervalued (260) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

6 PBV

The stock's high Price-to-Book Value (P/BV) ratio (9.3x) suggests it's overvalued, potentially making it an expensive investment.

7 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

9 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

10 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

11 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

Nanosonics Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Nanosonics Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Nanosonics Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Nanosonics Limited Revenue
Year Revenue Growth
2006 8.424
2007 0 0%
2008 309.000 100%
2009 763.000 59.5%
2010 2.247.000 66.04%
2011 12.301.000 81.73%
2012 14.899.000 17.44%
2013 21.492.000 30.68%
2014 22.214.000 3.25%
2015 42.796.000 48.09%
2016 67.507.000 36.61%
2017 60.649.000 -11.31%
2018 84.585.000 28.3%
2019 100.726.000 16.02%
2020 100.726.000 0%
2020 101.834.000 1.09%
2021 119.728.000 14.95%
2022 168.856.000 29.09%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Nanosonics Limited Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 390.000 100%
2008 3.435.000 88.65%
2009 2.369.000 -45%
2010 3.627.000 34.68%
2011 3.135.000 -15.69%
2012 3.167.000 1.01%
2013 4.103.000 22.81%
2014 4.902.000 16.3%
2015 7.297.000 32.82%
2016 9.488.000 23.09%
2017 9.882.000 3.99%
2018 11.375.000 13.13%
2019 15.558.000 26.89%
2020 15.558.000 0%
2020 17.194.000 9.51%
2021 22.358.000 23.1%
2022 31.756.000 29.59%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Nanosonics Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 4.820.340
2007 4.639.000 -3.91%
2008 5.098.000 9%
2009 4.929.000 -3.43%
2010 6.772.000 27.22%
2011 7.745.000 12.56%
2012 9.177.000 15.6%
2013 12.005.000 23.56%
2014 13.906.000 13.67%
2015 7.418.000 -87.46%
2016 9.041.000 17.95%
2017 9.734.000 7.12%
2018 10.716.000 9.16%
2019 12.965.000 17.35%
2020 12.965.000 0%
2020 16.003.000 18.98%
2021 20.283.000 21.1%
2022 24.434.000 16.99%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Nanosonics Limited EBITDA
Year EBITDA Growth
2006 -8.560.187
2007 -10.202.000 16.09%
2008 -10.098.000 -1.03%
2009 -9.118.000 -10.75%
2010 -12.973.000 29.72%
2011 -6.046.000 -114.57%
2012 -4.174.000 -44.85%
2013 -1.106.000 -277.4%
2014 -3.896.000 71.61%
2015 2.061.000 289.03%
2016 15.167.000 86.41%
2017 7.140.000 -112.42%
2018 19.199.000 62.81%
2019 16.695.000 -15%
2020 12.803.000 -30.4%
2020 15.748.000 18.7%
2021 7.862.000 -100.31%
2022 18.640.000 57.82%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Nanosonics Limited Gross Profit
Year Gross Profit Growth
2006 8.424
2007 0 0%
2008 188.000 100%
2009 479.000 60.75%
2010 1.266.000 62.16%
2011 7.502.000 83.12%
2012 8.471.000 11.44%
2013 13.921.000 39.15%
2014 15.313.000 9.09%
2015 32.166.000 52.39%
2016 50.155.000 35.87%
2017 45.242.000 -10.86%
2018 63.077.000 28.27%
2019 76.185.000 17.21%
2020 76.185.000 0%
2020 79.139.000 3.73%
2021 91.313.000 13.33%
2022 132.564.000 31.12%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Nanosonics Limited Net Profit
Year Net Profit Growth
2006 -5.703.524
2007 -7.147.000 20.2%
2008 -8.754.000 18.36%
2009 -8.172.000 -7.12%
2010 -11.214.000 27.13%
2011 -4.679.000 -139.67%
2012 -5.768.000 18.88%
2013 -2.605.000 -121.42%
2014 -5.460.000 52.29%
2015 122.000 4575.41%
2016 26.158.000 99.53%
2017 5.751.000 -354.84%
2018 13.602.000 57.72%
2019 10.137.000 -34.18%
2020 10.137.000 0%
2020 8.578.000 -18.17%
2021 3.742.000 -129.24%
2022 19.028.000 80.33%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Nanosonics Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Nanosonics Limited Free Cashflow
Year Free Cashflow Growth
2006 -5.298.051
2007 -7.503.000 29.39%
2008 -10.532.000 28.76%
2009 -7.944.000 -32.58%
2010 -10.179.000 21.96%
2011 -5.873.000 -73.32%
2012 -5.865.000 -0.14%
2013 -3.073.000 -90.86%
2014 -4.732.000 35.06%
2015 1.920.000 346.46%
2016 15.122.000 87.3%
2017 -5.634.000 368.41%
2018 2.591.000 317.45%
2019 20.876.000 87.59%
2020 5.945.000 -251.15%
2021 -271.000 2293.73%
2022 6.814.500 103.98%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Nanosonics Limited Operating Cashflow
Year Operating Cashflow Growth
2006 -4.586.396
2007 -7.135.000 35.72%
2008 -9.136.000 21.9%
2009 -7.762.000 -17.7%
2010 -9.001.000 13.77%
2011 -5.029.000 -78.98%
2012 -4.506.000 -11.61%
2013 -2.594.000 -73.71%
2014 -2.421.000 -7.15%
2015 3.224.000 175.09%
2016 16.388.000 80.33%
2017 -2.813.000 682.58%
2018 4.826.000 158.29%
2019 22.812.000 78.84%
2020 7.316.000 -211.81%
2021 6.695.000 -9.28%
2022 7.539.000 11.2%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Nanosonics Limited Capital Expenditure
Year Capital Expenditure Growth
2006 711.655
2007 368.000 -93.38%
2008 1.396.000 73.64%
2009 182.000 -667.03%
2010 1.178.000 84.55%
2011 844.000 -39.57%
2012 1.359.000 37.9%
2013 479.000 -183.72%
2014 2.311.000 79.27%
2015 1.304.000 -77.22%
2016 1.266.000 -3%
2017 2.821.000 55.12%
2018 2.235.000 -26.22%
2019 1.936.000 -15.44%
2020 1.371.000 -41.21%
2021 6.966.000 80.32%
2022 724.500 -861.49%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Nanosonics Limited Equity
Year Equity Growth
2006 31.317.211
2007 24.559.000 -27.52%
2008 16.312.000 -50.56%
2009 23.582.000 30.83%
2010 14.306.000 -64.84%
2011 26.003.000 44.98%
2012 21.707.000 -19.79%
2013 20.435.000 -6.22%
2014 44.676.000 54.26%
2015 56.664.000 21.16%
2016 87.251.000 35.06%
2017 94.303.000 7.48%
2018 110.083.000 14.33%
2019 124.230.000 11.39%
2020 135.568.000 8.36%
2021 138.691.000 2.25%
2022 163.860.000 15.36%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Nanosonics Limited Assets
Year Assets Growth
2006 33.396.993
2007 25.632.000 -30.29%
2008 17.582.000 -45.79%
2009 24.948.000 29.53%
2010 16.848.000 -48.08%
2011 36.660.000 54.04%
2012 33.653.000 -8.94%
2013 33.544.000 -0.32%
2014 60.365.000 44.43%
2015 68.169.000 11.45%
2016 99.256.000 31.32%
2017 109.181.000 9.09%
2018 129.521.000 15.7%
2019 147.070.000 11.93%
2020 162.304.000 9.39%
2021 187.671.000 13.52%
2022 219.920.000 14.66%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Nanosonics Limited Liabilities
Year Liabilities Growth
2006 2.079.782
2007 1.073.000 -93.83%
2008 1.270.000 15.51%
2009 1.366.000 7.03%
2010 2.542.000 46.26%
2011 10.657.000 76.15%
2012 11.946.000 10.79%
2013 13.109.000 8.87%
2014 15.689.000 16.44%
2015 11.505.000 -36.37%
2016 12.005.000 4.16%
2017 14.878.000 19.31%
2018 19.438.000 23.46%
2019 22.840.000 14.89%
2020 26.736.000 14.57%
2021 48.980.000 45.41%
2022 56.060.000 12.63%

Nanosonics Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.54
Net Income per Share
0.06
Price to Earning Ratio
64.4x
Price To Sales Ratio
7.59x
POCF Ratio
54.92
PFCF Ratio
63.79
Price to Book Ratio
7.81
EV to Sales
6.98
EV Over EBITDA
52.79
EV to Operating CashFlow
49.68
EV to FreeCashFlow
58.66
Earnings Yield
0.02
FreeCashFlow Yield
0.02
Market Cap
1,26 Bil.
Enterprise Value
1,16 Bil.
Graham Number
0.88
Graham NetNet
0.32

Income Statement Metrics

Net Income per Share
0.06
Income Quality
1.17
ROE
0.14
Return On Assets
0.07
Return On Capital Employed
0.06
Net Income per EBT
1.04
EBT Per Ebit
1.31
Ebit per Revenue
0.07
Effective Tax Rate
-0.04

Margins

Sales, General, & Administrative to Revenue
0.14
Research & Developement to Revenue
0.18
Stock Based Compensation to Revenue
0.03
Gross Profit Margin
0.79
Operating Profit Margin
0.07
Pretax Profit Margin
0.09
Net Profit Margin
0.09

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.08
Free CashFlow per Share
0.06
Capex to Operating CashFlow
-0.15
Capex to Revenue
-0.02
Capex to Depreciation
-0.51
Return on Invested Capital
0.09
Return on Tangible Assets
0.09
Days Sales Outstanding
85.22
Days Payables Outstanding
38.83
Days of Inventory on Hand
263.21
Receivables Turnover
4.28
Payables Turnover
9.4
Inventory Turnover
1.39
Capex per Share
-0.01

Balance Sheet

Cash per Share
0,36
Book Value per Share
0,53
Tangible Book Value per Share
0.53
Shareholders Equity per Share
0.53
Interest Debt per Share
0.03
Debt to Equity
0.07
Debt to Assets
0.05
Net Debt to EBITDA
-4.62
Current Ratio
5.5
Tangible Asset Value
0,16 Bil.
Net Current Asset Value
0,13 Bil.
Invested Capital
0.07
Working Capital
0,15 Bil.
Intangibles to Total Assets
0
Average Receivables
0,02 Bil.
Average Payables
0,00 Bil.
Average Inventory
25490000
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Nanosonics Limited Dividends
Year Dividends Growth

Nanosonics Limited Profile

About Nanosonics Limited

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

CEO
Mr. Michael C. Kavanagh BSc, M
Employee
482
Address
Building A
Macquarie Park, 2113

Nanosonics Limited Executives & BODs

Nanosonics Limited Executives & BODs
# Name Age
1 Mr. Michael C. Kavanagh BSc, M.B.A.
Chief Executive Officer, President, MD & Executive Director
70
2 Dr. Steven Farrugia B.E., Ph.D.
Chief Technology Officer
70
3 Mr. Keith Koby BSEET, MBA
Senior Vice President of Sales - North America
70
4 Mr. Matthew Lipscombe B.E., B.Sc., M.B.A.
Chief Marketing Officer
70
5 Jason Burriss
Chief Financial Officer
70
6 Mr. Rod Lopez M.B.A.
Chief Operating Officer & Regional President for Asia Pacific
70
7 Mr. Matthew Carbines B.Com., L.L.B.
General Counsel & Company Secretary
70
8 Ms. Jodi Sampson M.B.A.
Chief People & Culture Officer
70
9 Mr. Vincent Wang
Head of Global Customer Support & Technical Services
70
10 Mr. Sunny Pillai
Chief Information Officer
70

Nanosonics Limited Competitors

Pro Medicus Limited Logo
Pro Medicus Limited

PME.AX

(4.0)
Altium Limited Logo
Altium Limited

ALU.AX

(3.5)
Appen Limited Logo
Appen Limited

APX.AX

(1.5)
NEXTDC Limited Logo
NEXTDC Limited

NXT.AX

(0.8)